Fundraising Fox

Henrijette Richter

Investor

Managing Partner at Sofinnova Partners

Paris, France

Writes $100K – $5M checks · typically $1.5M

About

Managing Partner at Sofinnova Partners and member of the Sofinnova Capital Strategy team, its early-stage biotech and medtech fund. She joined in 2014 and has led life science investments including HAYA Therapeutics, Muna Therapeutics, NodThera, and Delinia (acquired by Celgene). Previously she helped build Novo Seeds from its 2007 founding and began her venture career at Sunstone Capital.

Contact· published on Henrijette's own website

Invests in

BiotechMedical Devices

Experience

  1. Sofinnova PartnersManaging Partnercurrent2017 — presentGreater Paris Metropolitan Region
  2. Sofinnova PartnersPartner2014 — 2017Greater Paris Metropolitan Region
  3. Mozart Therapeutics, IncBoard Membercurrent2021 — presentSeattle, Washington, United States
  4. Nitrase TherapeuticsBoard Membercurrent2020 — presentSan Francisco, California, United States
  5. Nitrase TherapeuticsBoard Membercurrent2020 — presentSan Francisco, California, United States
  6. Muna TherapeuticsBoard Membercurrent2021 — presentCopenhagen, Capital Region of Denmark, Denmark
  7. Muna TherapeuticsBoard Membercurrent2021 — presentCopenhagen, Capital Region of Denmark, Denmark
  8. Twentyeight-Seven TherapeuticsBoard Membercurrent2019 — presentWatertown, Massachusetts, United States
  9. Twentyeight-Seven TherapeuticsBoard Membercurrent2019 — presentWatertown, Massachusetts, United States
  10. NodThera LimitedBoard Membercurrent2019 — present
  11. NodThera LimitedChair Of The Board Of Directors2018 — 2019
  12. iOmx Therapeutics AGMember of The Supervisory Boardcurrent2019 — presentGreater Munich Metropolitan Area
  13. iOmx Therapeutics AGChair Of The Board Of Directors2016 — 2019Greater Munich Metropolitan Area
  14. Asceneuron SABoard Membercurrent2015 — presentLausanne, Vaud, Switzerland
  15. Comet TherapeuticsMember Board Of Directors2017 — 2021
  16. Karolinska DevelopmentMember Board of Directors2014 — 2017Greater Stockholm Metropolitan Area
  17. DeliniaMember of the Board2016 — 2017San Francisco Bay Area and Cambridge Massachusetts
  18. DeliniaFounding Chair of the Board2015 — 2016San Francisco Bay Area and Cambridge, Massachusetts
  19. GUDP, Ministry of Food, Agriculture, and Fisheries of DenmarkMember Board of Directors2010 — 2016Copenhagen Metropolitan Area
  20. LYSOGENEMember Board of Directors2014Greater Paris Metropolitan Region
  21. Affinicon ApSChairman Board of Directors2013 — 2014Aarhus, Denmark
  22. Avilex Pharma ApSMember Board of Directors2013 — 2014Copenhagen, Denmark
  23. EpiTherapeutics ApSMember Board of Directors2012 — 2014Copenhagen Metropolitan Area
  24. OrphazymeMember Board of Directors2010 — 2014Copenhagen Metropolitan Area
  25. Novo A/SInvestment Director2007 — 2014Copenhagen Metropolitan Area
  26. Cytoguide ApSChairman of the Board2010 — 2013Aarhus, Denmark
  27. Sunstone CapitalDirector of Scientific Analysis2007
  28. VaekstfondenDirector of Scientific Analysis2006 — 2007
  29. VaekstfondenInvestment Analyst2004 — 2006
  30. Massachusetts Institute of TechnologyPostdoctoral Fellow2002 — 2004
  31. Novo Nordisk A/SIndustrial PhD student1999 — 2002
  32. Hagedorn Research InstituteMaster student1997 — 1999

Skills & more

Investments12Finance5Lifesciences4Research1Biotechnology20Strategy16Funding8Start-ups9Mergers & Acquisitions8Business Strategy16Entrepreneurship9Business Development7
+3 morePharmaceutical IndustryGrantsVenture Capital

Languages English

From Henrijette's professional profile.

Investments

Investor

Avilex PharmaDeliniaEpiTherapeuticsFreya BiosciencesHaya TherapeuticsMozart TherapeuticsMuna TherapeuticsNanoPhoria BioscienceNodtheraOrphazyme

Per the firm's website.

Colleagues at Sofinnova Partners

Agnès Pauquet
Head of Human Resources at Sofinnova Partners
Ahmed Fourati
Investor Relations and Reporting Officer at Sofinnova Partners
Aishwarya Parthasarathy
Associate, Digital Medicine Strategy at Sofinnova Partners
Alex Leech
Partner, Biovelocita Strategy at Sofinnova Partners
Alexandra Abreu
Analyst, Crossover Strategy at Sofinnova Partners
Andrew M. Weiss
Venture Partner at Sofinnova Partners
Anis Belmili
Fund Accountant at Sofinnova Partners
Ankeet Jethwa
Senior Associate, Capital Strategy at Sofinnova Partners

Frequently asked questions

Who is Henrijette Richter?
Managing Partner at Sofinnova Partners and member of the Sofinnova Capital Strategy team, its early-stage biotech and medtech fund. She joined in 2014 and has led life science investments including HAYA Therapeutics, Muna Therapeutics, NodThera, and Delinia (acquired by Celgene). Previously she helped build Novo Seeds from its 2007 founding and began her venture career at Sunstone Capital.
Where does Henrijette Richter work?
Henrijette Richter is Managing Partner at Sofinnova Partners.
What does Henrijette Richter invest in?
Henrijette Richter invests in Biotech, Medical Devices.
What check size does Henrijette Richter write?
Henrijette Richter typically writes checks of $100K – $5M.
What companies has Henrijette Richter invested in?
Investments tracked here include Avilex Pharma, Delinia, EpiTherapeutics, Freya Biosciences, Haya Therapeutics, Mozart Therapeutics, Muna Therapeutics, NanoPhoria Bioscience, Nodthera, Orphazyme.
Where did Henrijette Richter go to school?
Henrijette Richter studied at Harvard Business School (executive course, Venture Capital and Private Equity); Copenhagen Business School (Executive Certificate, Business Administration with focus on Leadership and Business Essentials); Massachusetts Institute of Technology (Postdoctoral Fellow, Oncology and Cancer Biology).

Same school

Also attended Harvard Business School2,000

Brad GerstnerFounder & CEO of Altimeter CapitalMamoon HamidPartner at Kleiner PerkinsNeeraj AgrawalGeneral Partner at Battery VenturesVictoria TreygerGeneral Partner at Felicis VenturesDeep NisharInvestment Team at General CatalystAdrianna MaInvestor at Index Ventures

+ 1,994 more

Also attended Copenhagen Business School424

Jeppe RindomCo-founder & CEO of PleoLinaInvestor at InvestinorJonathan W.Deeptech Fellow at Clear VenturesAntonio GrifoniAssociate at P101 VenturesThomas JuvinManaging Director Europe at Burda Principal InvestmentsAlexander KremerPartner at Keen Venture Partners

+ 418 more

Also attended Massachusetts Institute of Technology1,521

Fred WilsonCo-founder & Partner at Union Square VenturesElad GilSolo general partner investing through Gil CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystNat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDGBrad FeldCo-founder of Foundry and Techstars

+ 1,515 more

Also attended Københavns Universitet - University of Copenhagen143

David HelgasonUnity co-founder; Partner at TransitionJesper GromadaInvestor at Third Rock VenturesUlrik B. NielsenGeneral Partner at Mission BiocapitalNana Kusi MinkahAccounting and Operations Associate at Mission BiocapitalTommy AhlersFormer Danish Science Minister at Giant Ventures Global LlpRafael Jara-SimkinHead of Sales Intelligence at Theory Ventures

+ 137 more

Shared employers

Also worked at NodThera Limited4

Mira ChaurushiyaManaging Director at Westlake Village BioPartnersKatie Bodner SpielbergPrincipal at 5AM VenturesAlex PasteurPartner at F-Prime Capital PartnersZhizhong YaoPartner at Sofinnova Partners

Also worked at iOmx Therapeutics AG1

Keno GutierrezGeneral Partner at BioGeneration Ventures

Also worked at Delinia1

Jeffrey TongPartner at Third Rock Ventures

Also worked at Vaekstfonden27

Søren LemoniusManaging General Partner at Sunstone CapitalClaus AnderssonGeneral Partner at Sunstone CapitalLine JacobsenManagement Assistant at Sunstone CapitalMerete Lundbye MøllerVenture Partner, General Counsel at Sunstone CapitalTine LindgreenPrincipal at SEED Capital DenmarkLene GerlachVenture Partner at Hadean Ventures

+ 21 more